Association of a beta-2 adrenoceptor (ADRB2) gene variant with a blunted in vivo lipolysis and fat oxidation

International Journal of Obesity

Volumn 31, Issue 5, 2007, Pages 813-819

  Jocken, J W E ^a,c   Blaak, E E ^a   Schiffelers, S ^a   Arner, P ^b   Van Baak, M A ^a   Saris, W H M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

ADRB2 gene; Fat oxidation; GNB3 gene; Lipolysis; Single nucleotide polymorphism

Indexed keywords

ARGININE; BETA 2 ADRENERGIC RECEPTOR; FATTY ACID; GLYCEROL; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; ISOPRENALINE;

ADRENERGIC STIMULATION; ADRENERGIC SYSTEM; ADULT; ALLELE; ARTICLE; BODY MASS; CODON; CONTROLLED STUDY; ENERGY EXPENDITURE; EXON; FATTY ACID BLOOD LEVEL; FATTY ACID OXIDATION; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GLYCEROL BLOOD LEVEL; HUMAN; LIPOLYSIS; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RESPIRATORY QUOTIENT; SEX DIFFERENCE;

ADIPOSE TISSUE; ADRENERGIC BETA-AGONISTS; ADULT; ANTHROPOMETRY; ENERGY METABOLISM; FEMALE; HETEROTRIMERIC GTP-BINDING PROTEINS; HUMANS; ISOPROTERENOL; LIPOLYSIS; MALE; OBESITY; OXIDATION-REDUCTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADRENERGIC, BETA-2; VARIATION (GENETICS);

EID: 34247519217     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/sj.ijo.0803499     Document Type: Article

References (48)

1. Blaak EE, Van Baak MA, Kemerink GJ, Pakbiers MT, Heidendal GA, Saris WH. Beta-adrenergic stimulation of skeletal muscle metabolism in relation to weight reduction in obese men. Am J Physiol 1994; 267 (2 Part 1): E316-E322.
2. Blaak EE, Saris WH, Wolffenbuttel BH. Substrate utilization and thermogenic responses to beta-adrenergic stimulation in obese subjects with NIDDM. Int J Obes Relat Metab Disord 1999; 23: 411-418.
3. Blaak EE, van Aggel-Leijssen DP, Wagenmakers AJ, Saris WH, van Baak MA. Impaired oxidation of plasma-derived fatty acids in type 2 diabetic subjects during moderate-intensity exercise. Diabetes 2000; 49: 2102-2107.
4. Blaak EE, Van Baak MA, Kemerink GJ, Pakbiers MT, Heidendal GA, Saris WH. Beta-adrenergic stimulation of energy expenditure and forearm skeletal muscle metabolism in lean and obese men. Am J Physiol 1994; 267 (2 Part 1): E306-E315.
5. Schiffelers SL, Blaak EE, Baarends EM, Van Baak MA, Saris WH, Wouters EF et al. Beta-adrenoceptor-mediated thermogenesis and lipolysis in patients with chronic obstructive pulmonary disease. Am J Physiol Endocrinol Metab 2001; 280: E357-E364.
6. Reynisdottir S, Wahrenberg H, Carlstrom K, Rossner S, Arner P. Catecholamine resistance in fat cells of women with upper body obesity due to decreased expression of beta 2-adrenoceptors. Diabetologia 1994; 37: 428-435.
7. Kobilka BK, MacGregor C, Daniel K, Kobilka TS, Caron MG, Lefkowitz RJ. Functional activity and regulation of human beta 2-adrenergic receptors expressed in Xenopus oocytes. J Biol Chem 1987; 262: 15796-15802.
8. Kobilka BK, Frielle T, Dohlman HG, Bolanowski MA, Dixon RA, Keller P et al. Delineation of the intronless nature of the genes for the human and hamster beta 2-adrenergic receptor and their putative promoter regions. J Biol Chem 1987; 262: 7321-7327.
9. Liggett SB. Pharmacogenetics of beta-1- and beta-2-adrenergic receptors. Pharmacology 2000; 61: 167-173.
10. Leineweber K, Brodde OE. Beta2-adrenoceptor polymorphisms: relation between in vitro and in vivo phenotypes. Life Sci 2004; 74: 2803-2814.
11. Green SA, Turki J, Innis M, Liggett SB. Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 1994; 33: 9414-9419.
12. Bengtsson K, Orho-Melander M, Melander O, Lindblad U, Ranstam J, Rastam L et al. Beta(2)-adrenergic receptor gene variation and hypertension in subjects with type 2 diabetes. Hypertension 2001; 37: 1303-1308.
13. Kim SH, Kim DJ, Seo IA, Min YK, Lee MS, Kim KW et al. Significance of beta2-adrenergic receptor gene polymorphism in obesity and type 2 diabetes mellitus in Korean subjects. Metabolism 2002; 51: 833-837.
14. Iwamoto N, Ogawa Y, Kajihara S, Hisatomi A, Yasutake T, Yoshimura T et al. Gln27Glu beta2-adrenergic receptor variant is associated with hypertriglyceridemia and the development of fatty liver. Clin Chim Acta 2001; 314: 85-91.
15. Ukkola O, Rankinen T, Weisnagel SJ, Sun G, Perusse L, Chagnon YC et al. Interactions among the alpha2-, beta2-, and beta3-adrenergic receptor genes and obesity-related phenotypes in the Quebec family study. Metabolism 2000; 49: 1063-1070.
16. Large V, Hellstrom L, Reynisdottir S, Lonnqvist F, Eriksson P, Lannfelt L et al. Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function. J Clin Invest 1997; 100: 3005-3013.
17. Hellstrom L, Large V, Reynisdottir S, Wahrenberg H, Arner P. The different effects of a Gln27Glu beta 2-adrenoceptor gene polymorphism on obesity in males and in females. J Intern Med 1999; 245: 253-259.
18. Meirhaeghe A, Helbecque N, Cottel D, Amouyel P. Impact of polymorphisms of the human beta2-adrenoceptor gene on obesity in a French population. Int J Obes Relat Metab Disord 2000; 24: 382-387.
19. Meirhaeghe A, Helbecque N, Cottel D, Amouyel P. Beta2-adrenoceptor gene polymorphism, body weight, and physical activity. Lancet 1999; 353: 896.
20. Mori Y, Kim-Motoyama H, Ito Y, Katakura T, Yasuda K, Ishiyama-Shigemoto S et al. The Gln27Glu beta2-adrenergic receptor variant is associated with obesity due to subcutaneous fat accumulation in Japanese men. Biochem Biophys Res Commun 1999; 258: 138-140.
21. Ishiyama-Shigemoto S, Yamada K, Yuan X, Ichikawa F, Nonaka K. Association of polymorphisms in the beta2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus. Diabetologia 1999; 42: 98-101.
22. Oomen JM, van Rossum CT, Hoebee B, Saris WH, van Baak MA. Beta2-adrenergic receptor polymorphisms and salbutamol-stimulated energy expenditure. J Clin Endocrinol Metab 2005; 90: 2301-2307.
23. Green SA, Cole G, Jacinto M, Innis M, Liggett SB. A polymorphism of the human beta 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. J Biol Chem 1993; 268: 23116-23121.
24. Green SA, Rathz DA, Schuster AJ, Liggett SB. The Ile164 beta(2)-adrenoceptor polymorphism alters salmeterol exosite binding and conventional agonist coupling to G(s). Eur J Pharmacol 2001; 421: 141-147.
25. Hoffstedt J, Iliadou A, Pedersen NL, Schalling M, Arner P. The effect of the beta(2) adrenoceptor gene Thr164Ile polymorphism on human adipose tissue lipolytic function. Br J Pharmacol 2001; 133: 708-712.
26. Siffert W, Rosskopf D, Siffert G, Busch S, Moritz A, Erbel R et al. Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet 1998; 18: 45-48.
27. Patten JL, Johns DR, Valle D, Eil C, Gruppuso PA, Steele G et al. Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright's hereditary osteodystrophy. N Engl J Med 1990; 322: 1412-1419.
28. Carel JC, Le Stunff C, Condamine L, Mallet E, Chaussain JL, Adnot P et al. Resistance to the lipolytic action of epinephrine: a new feature of protein Gs deficiency. J Clin Endocrinol Metab 1999; 84: 4127-4131.
29. Schunkert H, Hense HW, Doring A, Riegger GA, Siffert W. Association between a polymorphism in the G protein beta3 subunit gene and lower renin and elevated diastolic blood pressure levels. Hypertension 1998; 32: 510-513.
30. Benjafield AV, Jeyasingam CL, Nyholt DR, Griffiths LR, Morris BJ. G-protein beta3 subunit gene (GNB3) variant in causation of essential hypertension. Hypertension 1998; 32: 1094-1097.
31. Siffert W, Forster P, Jockel KH, Mvere DA, Brinkmann B, Naber C et al. Worldwide ethnic distribution of the G protein beta3 subunit 825 T allele and its association with obesity in Caucasian, Chinese, and Black African individuals. J Am Soc Nephrol 1999; 10: 1921-1930.
32. Dong Y, Zhu H, Wang X, Dalageorgou C, Carter N, Spector TD et al. Obesity reveals an association between blood pressure and the G-protein beta3-subunit gene: a study of female dizygotic twins. Pharmacogenetics 2004; 14: 419-427.
33. Hauner H, Meier M, Jockel KH, Frey UH, Siffert W. Prediction of successful weight reduction under sibutramine therapy through genotyping of the G-protein beta3 subunit gene (GNB3) C825T polymorphism. Pharmacogenetics 2003; 13: 453-459.
34. Hegele RA, Anderson C, Young TK, Connelly PW. G-protein beta3 subunit gene splice variant and body fat distribution in Nunavut Inuit. Genome Res 1999; 9: 972-977.
35. Ryden M, Faulds G, Hoffstedt J, Wennlund A, Arner P. Effect of the (C825T) Gbeta(3) polymorphism on adrenoceptor-mediated lipolysis in human fat cells. Diabetes 2002; 51: 1601-1608.
36. Siri WE. The gross composition of the body. Adv Biol Med Phys 1956; 4: 239-280.
37. Devlin B, Risch N. A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 1995; 29: 311-322.
38. Eriksson P, Dahlman I, Ryden M, Hoffstedt J, Arner P. Relationship between beta-2 adrenoceptor gene haplotypes and adipocyte lipolysis in women. Int J Obes Relat Metab Disord 2004; 28: 185-190.
39. Drysdale CM, McGraw DW, Stack CB, Stephens JC, Judson RS, Nandabalan K et al. Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci USA 2000; 97: 10483-10488.
40. Schaid DJ, Jacobsen SJ. Biased tests of association: comparisons of allele frequencies when departing from Hardy-Weinberg proportions. Am J Epidemiol 1999; 149: 706-711.
41. Blaak EE, van Baak MA, Saris WH. Beta-adrenergically stimulated fat oxidation is diminished in middle-aged compared to young subjects. J Clin Endocrinol Metab 1999; 84: 3764-3769.
42. Kanaley JA, Cryer PE, Jensen MD. Fatty acid kinetic responses to exercise. Effects of obesity, body fat distribution, and energyrestricted diet. J Clin Invest 1993; 92: 255-261.
43. Blaak E. Gender differences in fat metabolism. Curr Opin Clin Nutr Metab Care 2001; 4: 499-502.
44. Arner P. Catecholamine-induced lipolysis in obesity. Int J Obes Relat Metab Disord 1999; 23 (Suppl 1): 10-13.
45. Blaak EE, Schiffelers SL, Saris WH, Mensink M, Kooi ME. Impaired beta-adrenergically mediated lipolysis in skeletal muscle of obese subjects. Diabetologia 2004; 47: 1462-1468.
46. Dallongeville J, Helbecque N, Cottel D, Amouyel P, Meirhaeghe A. The Gly16- > Arg16 and Gln27- > Glu27 polymorphisms of beta2-adrenergic receptor are associated with metabolic syndrome in men. J Clin Endocrinol Metab 2003; 88: 4862-4866.
47. Hagstrom-Toft E, Bolinder J, Ungerstedt U, Arner P. A circadian rhythm in lipid mobilization which is altered in IDDM. Diabetologia 1997; 40: 1070-1078.
48. Bruck H, Leineweber K, Buscher R, Ulrich A, Radke J, Insel PA et al. The Gln27Glu beta2-adrenoceptor polymorphism slows the onset of desensitization of cardiac functional responses in vivo. Pharmacogenetics 2003; 13: 59-66.